Correction Pharmaceuticals has won a number of honors!The 2023 China OTC Brand List was released

Mondo Social Updated on 2024-01-31

On December 22-24, the first OTC brand conference was held in Beijing. This conference was hosted by the China Non-prescription Drug Association, and the 2023 China OTC Brand List was released, and the amendment group and its products won a number of honors!

As an OTC product for gastrointestinal diseases, Starshu provides a convenient and effective self-medication option for the majority of patients, which is of great significance to protect people's health. The award of many OTC products is not only an affirmation of Correction Pharmaceutical's drug R&D and production, but also a recognition of the contribution of Amendment's products to protect people's livelihood. Note: OTC products, i.e., over-the-counter drugs, are those that can be used at your own discretion without a doctor's prescription. With the theme of "Believe in the Power of Brands", this conference aims to build an "industry ecological platform" to promote the high-quality development of OTC brands, and will bring together the main forces of core elements such as politics, industry, learning, use, media, and services in the field of OTC brands, and focus on core issues such as hot policies, development trends, innovation and upgrading, and professional communication of China's OTC brands, so as to provide new thinking, new impetus and new models for the development of China's OTC brands.

For China, the popularization and development of OTC products plays an important role in ensuring people's livelihood. First of all, OTC products can facilitate the general public to carry out self-diagnosis and treatment in the family environment, reduce the number and cost of medical treatment, and improve medical efficiency. Secondly, the safety of OTC products is high, and there will be no serious problems under normal circumstances, so that people can choose to deal with some common diseases at home, which effectively relieves the pressure on hospitals and saves medical resources.

As a pharmaceutical company dominated by the C-end OTC market, we have always adhered to the core principle of "genuine, sufficient, symptomatic, and methodical" since 1995, when the Class A OTC product Lung Ning Oral Liquid was approved for marketing, to the development and marketing of Lung Qinghuo Tablets, Kidney and Tranquility Oral Liquid, etc., in recent years. In addition to the award-winning Starshu, we have also successfully created a series of well-known OTC products, including Xiaoxiao Suppository, Tongqi Rhinitis Tablets, Hemorrhoids Suppository, Erding Granules, Compound Honeysuckle Granules, Qi Nourishing Blood Nourishing Oral Liquid, and Lung Ning Granules, all of which are trusted by consumers. We use the group's own modified health applets and apps, combined with 15 sales platforms and a nationwide OTC market network, to provide our customers with personalized medication advice, real-time health consultation and other more thoughtful and convenient services. Through these platforms, we have realized the full-link service from OTC products** to online free medication consultation, from free short** health science popularization to online comprehensive healthy life management.

Adhering to the concept of "cultivating virtue and righteousness, creating infinity", we are committed to promoting model innovation across the entire industry chain to ensure that the health needs of consumers are accurately met. As a key force in ensuring people's livelihood and building a quality power, we will continue to promote the high-quality development of the OTC industry and lead industry innovation.

Related Pages